Albendazole CAS 54965-21-8: Comprehensive User Guide
Table of Contents
- Product Overview & Specifications
- Detailed Applications
- Usage Scenarios
- Client Success Stories
- Contact for Technical Consultation
Product Specifications
| Parameter | Albendazole | Mebendazole | Ivermectin |
|---|---|---|---|
| CAS Number | 54965-21-8 | 31431-39-7 | 70288-86-7 |
| Molecular Formula | C12H15N3O2S | C16H13N3O3 | C48H74O14 |
| Mechanism | Microtubule disruption | Glucose uptake inhibition | Glutamate-gated chloride channel activation |
Therapeutic Applications
Albendazole demonstrates broad-spectrum efficacy against:
- Neurocysticercosis (tapeworm larvae)
- Hydatid disease (Echinococcus granulosus)
- Soil-transmitted helminths (Ascaris, hookworms)
- Veterinary parasitic infections
Clinical Protocols
Human Dosage:
| Condition | Dosage | Duration |
|---|---|---|
| Hydatid Disease | 400mg bid | 28-day cycles with 14-day intervals |
| Neurocysticercosis | 15mg/kg/day | 8-30 days depending on cyst location |
Client Implementation Cases
Case 1: Veterinary Clinic in India
- Client: New Delhi Animal Care Center
- Challenge: Recurring nematode infections in cattle
- Solution: 10mg/kg albendazole oral suspension for 5 days
- Outcome: 92% fecal egg count reduction
Case 2: Hospital Parasitology Unit
- Client: São Paulo Tropical Disease Center
- Application: Mass deworming program
- Regimen: Single 400mg dose to 15,000 patients
- Result: 84% reduction in helminth prevalence
Technical Consultation
For formulation support or bulk purchasing:
- Email: info@vivalr.com
- Tel: (86) 15866781826



评论
目前还没有评论。